1 Two thousand, one hundred and seventy-three patients with cancer or chronic infections were treated with coumarin in a clinical trial.
2 0.37% of these patients developed elevated liver enzyme levels during therapy with coumarin.
3 This hepatitis was probably a form of idiosyncratic hepatotoxicity and may have been immune in origin.
Get full access to this article
View all access options for this article.
References
1.
Feuer G.The metabolism and biological actions of coumarins. Progress in Medicinal Chemistry1974; 10: 85-158.
2.
Hazelton LW, Tusing TW, Zeitlin BR, Theissen R. & Murer HKToxicity of coumarin. Journal of Pharmacology and Experimental Therapy1956; 116: 248-58. 3 Federal Regulations1954; 19: 1239.
3.
Evans JG, Gaunt IF & Lake BGTwo year toxicity study on coumarin in the baboon. Food and Cosmetic Toxicology1979; 17: 187-93.
4.
Schilling WH , Crampton RF & Longland RGMetabolism of coumarin in Man. Nature (London)1969; 221: 664-6.
5.
Moran E., O'Kennedy R. & Thornes RDAnalysis of coumarin and its urinary metabolites by high performance liquid chromatography. Journal of Chromatography1987; 416: 165-9.
6.
Faurschou P.Toxic hepatitis due to benzo-pyrone. Human Toxicology1982; 1: 149-50.
7.
Thornes RD, Lynch G. & Sheehan MVCimetidine and coumarin therapy of melanoma. Lancet1982; ii: 328.
8.
Thornes RDCoumarin, melanoma and cellular immunity. Protective Agents in Cancer pp. 43-56. London: Academic Press, 1983.
9.
Zanker KS, Blumel G., Lange J. & Siewert JRCoumarin in melanoma patients: an experimental and clinical study . Drugs and Experimental Clinical Research1984; X: 767-74.
10.
Zanker KSEnd point results of a four year adjuvant melanoma trial for stage I and II patients with 1, 2-benzopyrone. Abstract of 5th International Conference on the Adjuvant Therapy of Cancer, 1987, Tuscon, Arizona, USA.
11.
Marshall ME , Mendelshon L., Butler K., Metcalfe M., Harvey J. & MacDonald JSTreatment of metastatic malignant melanoma with coumarin and cimetidine. Proceedings of the American Society for Clinical Oncology1986; 5; 136.
12.
Marshall ME , Mendelsohn L., Butler , K., et al. Treatment of metastatic renal cell carcinoma with coumarin (1,2-benzopyrone) and cimetidine: a pilot study. Journal of Clinical Oncology1987; 5: 862-6.
13.
Thornes RDThe anergy of chronic human brucellosis. Journal of the Irish Medical Association1977; 70: 480-3.
14.
Tseng A., Synder J., Lee W., et al. Prevention of tumorigenesis of inducible EJ-ras oncogene-containing rat-1 cells with drugs that interact with the poly (ADPribose) polymerase system. Proceedings of the American Association for Cancer Research1986; 27: 145.
15.
Conley D. & Marshall MEEffects of coumarin on human tumour cell growth and cell cycle analysis in vitro. Proceedings of the American Association for Cancer Research1987; 28: 63.
16.
Cox, D., Moran E., Prosser E. & O'Kennedy R.Comparison of the effects of coumarin and 7-hydroxy-coumarin on the in vitro growth of tumour cell lines. Submitted for publication.
17.
Marshall ME , Riley L., Rhoades J., et al. Quantitative effects of coumarin and cimetidine on peripheral blood lymphocytes and natural killer (NK) cells in patients with advanced malignancies. Proceedings of the American Association for Cancer Research1987; 28: 186.
18.
Marshall ME , Riley LK, Rhoades J., et al. Effects of coumarin (1,2-benzopyrone) and cimetidine on peripheral blood lymphocytes, natural killer cells and monocytes in patients with advanced malignancies. Journal of Biological Response Modifiers, 1989; 8: 62-9.
19.
Wattenberg LW, Tam LK & Fladmore AVInhibition of chemical carcinogen-induced neoplasia by coumarins and α-angelicolactone. Cancer Research1979; 39: 1651-4.
20.
Feuer G., Kellen JA & Kovacs K.Suppression of 7, 12-dimethylbenz(a)anthracene-induced breast carcinoma by coumarin in the rat. Oncology1976; 33: 35-9.
21.
Parente L., Koh MS, Willoughby DA & Kitchen A.Studies on cell motility in inflammation II. The in vivo effect of anti-inflammatory and anti-rheumatic drugs on chemotaxis in vitro. Agents Actions1979; 9: 196-200.
22.
Clodius L. & Piller NBConservative therapy for postmastectomy lymphedema. Chirurgia Plastica (Berl) 1978; 4: 193-202.
23.
Piller NBThe ineffectiveness of coumarin treatment on thermal oedema of macrophage-free rats. British Journal of Experimental Pathology1976; 57: 170-8.
24.
Piller NBA morphological assessment of the stimulatory effect of coumarin on macrophages . British Journal of Experimental Pathology1978; 59: 93-6.
25.
Zimmerman HJHypersensitivity to drugs. In International Encylopedia of Pharmacology and Therapeutics, Section 75, Volume 1. eds M. Santer & CW Parker , pp. 299-365. New York. Pergamon Press, 1972.
26.
Shoham J.Specific safety problems of inappropriate immune responses to immunostimulating agents. Trends in Pharmacological Science1985; 6: 178-82.
